ArticleTransfusion2026
Glycan-binding specificities of anti-ABO(H) antibodies and lectins.
Article in Transfusion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycan-binding specificities of anti-ABO(H) antibodies and lectins.Transfusion · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundABO blood type is critically important for blood transfusion and organ transplantation. Blood group reactive glycan-binding proteins are used as reagents in clinical and research laboratories to detect the glycan epitopes that define ABO blood type. The glycan specificities of these clinically used reagents are not well defined. METHODS AND MATERIALS: We used a glycan microarray to evaluate the specificities of a series of ABO(H) glycan-binding proteins: Ulex europaeus agglutinin I (UEA-I), Helix pomatia agglutinin (HPA), Dolichos biflorus agglutinin (DBA), anti-A antibody, and anti-B antibody.
resultsUEA-I binds many but not all H antigens and binds to some glycans that do not have the H antigen. HPA binds to terminal α-linked N-acetylgalactosamine, as found in the A antigen, but also to glycans with other terminal monosaccharides. DBA shows comparatively low binding to A antigens and binds more strongly to GM2 ganglioside sugar and Forssman antigens. Anti-A and anti-B monoclonal antibodies that are used for clinical ABO blood type determination demonstrate superior specificity compared to the lectins.
conclusionsThis glycan microarray data expands our understanding of the glycan specificities of commonly used ABO blood group binding reagents and indicates that caution should be used in interpretations of their binding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.